简体中文English

SRD (1p36) gene deletion probe reagent
Wholesale Price(RMB):

30006000330066003300660036007200

Product Code:R-0501102Ⅰ-01/R-0501102Ⅰ-02/R-0501102Ⅱ-01/R-0501102Ⅱ-02/R-0501102Ⅲ-01/R-0501102Ⅲ-02/R-0501102Ⅳ-01/R-0501102Ⅳ-02
Probe name:GSP SRD / GSP PBX1
Product Code:Type I (direct FISH method)/Type II (biotin-labeled indirect FISH method)/Type III (digoxigenin-labeled indirect FISH method)/Type IV (TSA-FISH method)
Registration Number:
Clinical Value

Renal Tumors

Nephroblastoma (Wilmstumor) is often associated with 1p36 deletion and 1q21-25 acquisition, often in association with 11p deletion (F.01346-01) and 16q deletion (F.01345-01).


Peripheral nerve tissue tumors and tumor-like lesions

deletion is associated with neuroblastoma recurrence, often in association with MYCN (F.01013-01) and KMT2A (11q23) (F.01308-01) gene deletions.


Other solid tumors

Deletion of the 1p36 region (SRD gene) can occur in a variety of tumors such as gliomas/leukemias/lymphomas/neuroblastomas;

In neuroblastomas (the most common extracranial tumors in children) 1p36 is the most typical genetic alteration.


Lymphoma

The 2016 WHO guidelines added the subtype of “1p36-deficient diffuse follicular lymphoma”, grade 1-2, large inguinal mass, limited lesions, CD10/BCL2/BCL6/CD23 positivity with 1p36 deletion, better prognosis.